Market Cap

e-therapeutics plc Market Capitalization:

£65.7 Million

GBP as of Jan. 1, 2024

US$83.6 Million

business e-therapeutics plc Company Profile

e-therapeutics plc Main Stock Listing

LSE: ETX

Market Capitalization History of e-therapeutics plc

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of e-therapeutics plc market cap

Date Market Cap YoY Change
Jan. 1, 2024 £65.7 M -28.84%
Jan. 1, 2023 £92.3 M -50.90%
Jan. 1, 2022 £188.0 M 79.87%
Jan. 1, 2021 £104.5 M 396.67%
Jan. 1, 2020 £21.0 M -28.57%
Jan. 1, 2019 £29.5 M -45.45%
Jan. 1, 2018 £54.0 M 11.59%
Jan. 1, 2017 £48.4 M -64.80%
Jan. 1, 2016 £137.5 M -20.97%
Jan. 1, 2015 £174.0 M 37.78%
Jan. 1, 2014 £126.3 M -30.77%
Jan. 1, 2013 £182.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +284.14%

$10,000 in April 2023 would now be $38,414 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

e-therapeutics plc Categories

United Kingdom languages Healthcare languages Biotechnology
United Kingdom Healthcare United Kingdom Biotechnology

Stocks & Indices

e-therapeutics plc has the following listings and related stock indices.


Stock: LSE: ETX

Stock: OTC: ETXPF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.